Article Detail - JF Part B

Date Posted: February 5, 2026

This Local Coverage Determination (LCD) has been revised under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: March 5, 2023

Summary of Changes:

COVERAGE INDICATIONS:

Revised sentence from "(Please refer to CMS, Publication 100-3, Medical National Coverage Determinations Manual (NCD), Chapter 1, Part 2, §110.23)" to "(Please refer to CMS, Publication 100-03, Medicare National Coverage Determinations Manual (NCD), Chapter 1, Part 2, §110.23)"

Revised sentence from "Per the NCD, "All other indications for stem cell transplantation not otherwise noted above as covered or non-covered remain at local Medicare Administrative Contractor (MAC) discretion." "to "Per the NCD, "Coverage of all other indications for stem cell transplantation not otherwise specified above as covered or non-covered will be made by local Medicare Administrative Contractors under sections 1862(a)(1)(A).""

SUMMARY OF EVIDENCE:

Added parentheses for acronym Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Revised sentence from "The CMS National Coverage Determination (NCD 110.23) for Stem Cell Transplantation describes nationally covered indications for, the details of which will not be fully repeated within this policy. This policy describes additional locally covered indications for stem cell transplant, without exclusion of the disease entities considered in this Policy." To "The CMS National Coverage Determination (NCD 110.23) for Stem Cell Transplantation describes nationally covered indications for stem cell transplant without exclusion of the disease entities considered in this Policy.""

ANALYSIS OF EVIDENCE:

Revised the acronym from Allo-HCT to Allo-HSCT

Visit the Noridian Active LCDs webpage to view the Active LCD or access it via the CMS MCD.